Morningstar
•
May 08, 2026
Boston Scientific Corporation: Boston Scientific: Despite Solid Quarterly Results, Muted Outlook Cause Shares to Oscillate
Summary
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The fi
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Bristol-Myers Squibb Company
May 12, 2026
•
BMY
Analyst Report: Stryker Corp
May 12, 2026
•
SYK
Market Digest: NOV, SYK, PPC, ABNB, RDDT
May 12, 2026
•
PPC, NOV, RDDT, SYK, ABNB
Analyst Report: Medtronic plc
May 11, 2026
•
MDT
Analyst Report: Intuitive Surgical, Inc.
May 11, 2026
•
ISRG
Analyst Profile
Debbie S. Wang
Senior Equity Analyst
Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald/s, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.
